Drugs / Conventional Insulin Aspart
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT04414579 Comparator | Mar 2019 → Mar 2021 | type 1 diabetes mellitus | Mountain Diabetes and Endocrine Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Conventional Insulin Aspart | “Conventional Insulin Aspart (NovoLog®)” NCT04414579 ↗ |
| Known as | NovoLog | “Conventional Insulin Aspart (NovoLog®)” NCT04414579 ↗ |
| Route | Subcutaneous | “Aspart is put into their pump and delivered to their body through a small tube placed under your skin.” NCT04414579 ↗ |